2026

Press Release: Belén Garijo to become Chief Executive Officer of Sanofi

Press Release: Sanofi completes the acquisition of Dynavax

Press Release: Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia

Press Release: Sanofi announces the signing of a share buyback mandate for up to €1 billion

Press Release: Sanofi’s venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher disease

Press Release: Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease

Press release: 2025: strong sales and EPS growth. Continued profitable growth expected in 2026

Press Release: Sanofi's amlitelimab confirms its potential in atopic dermatitis

Press Release: Myqorzo and Redemplo approved in China

Press Release: Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes

Press Release: Sanofi’s Tzield accepted for priority review in the US for young children with stage 2 type 1 diabetes